In mouse models of highfat dietinduced liver steatosis, it significantly inhibits hepatic NNMT activity, reduces NAM methylation, increases NAD+ and SAM levels, enhances mitochondrial fatty acid oxidation, reduces hepatic triglyceride and lipid accumulation, lowers lipotoxicity markers (e.g., malondialdehyde, transaminases), improves hepatocellular injury, and reverses steatosis
This critical difference means it functions as a targeted lipolytic agent rather than a systemic hormone, allowing for fat metabolism enhancement without the appetite disruptions, cortisol elevation, or blood sugar effects associated with growth hormone therapy
The ingredients in Lipostat+ injections help your body metabolize fats more efficiently, breaking down stubborn fat deposits and supporting liver function
Some patients are advised to supplement with vitamin B12 while taking semaglutide, as GLP-1 medications can sometimes affect nutrient absorption
A short, sharp pain during the injection may be felt
Persistent or severe headaches warrant medical attention